4//SEC Filing
ARCH VENTURE FUND V LP 4
Accession 0001012975-10-000380
CIK 0001298521other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 4:18 PM ET
Size
26.9 KB
Accession
0001012975-10-000380
Insider Transaction Report
Form 4
HEALTHCARE FOCUS FUND LP
10% Owner
Transactions
- Sale
Common Stock
2010-10-28−14,503→ 0 total - Sale
Common Stock
2010-10-28−132,802→ 0 total - Sale
Common Stock
2010-10-28−2,209,741→ 0 total
ARCH VENTURE PARTNERS V LP
10% Owner
Transactions
- Sale
Common Stock
2010-10-28−2,209,741→ 0 total - Sale
Common Stock
2010-10-28−14,503→ 0 total - Sale
Common Stock
2010-10-28−132,802→ 0 total
ARCH VENTURE PARTNERS V LLC
10% Owner
Transactions
- Sale
Common Stock
2010-10-28−2,209,741→ 0 total - Sale
Common Stock
2010-10-28−14,503→ 0 total - Sale
Common Stock
2010-10-28−132,802→ 0 total
BYBEE CLINTON
10% Owner
Transactions
- Sale
Common Stock
2010-10-28−2,209,741→ 0 total - Sale
Common Stock
2010-10-28−14,503→ 0 total - Sale
Common Stock
2010-10-28−132,802→ 0 total
LAZARUS STEVEN
10% Owner
Transactions
- Sale
Common Stock
2010-10-28−14,503→ 0 total - Sale
Common Stock
2010-10-28−132,802→ 0 total - Sale
Common Stock
2010-10-28−2,209,741→ 0 total
NELSEN ROBERT
10% Owner
Transactions
- Sale
Common Stock
2010-10-28−132,802→ 0 total - Sale
Common Stock
2010-10-28−2,209,741→ 0 total - Sale
Common Stock
2010-10-28−14,503→ 0 total
ARCH VENTURE FUND V LP
10% Owner
Transactions
- Sale
Common Stock
2010-10-28−132,802→ 0 total - Sale
Common Stock
2010-10-28−2,209,741→ 0 total - Sale
Common Stock
2010-10-28−14,503→ 0 total
CRANDELL KEITH
10% Owner
Transactions
- Sale
Common Stock
2010-10-28−2,209,741→ 0 total - Sale
Common Stock
2010-10-28−132,802→ 0 total - Sale
Common Stock
2010-10-28−14,503→ 0 total
ARCH V ENTREPRENEURS FUND LP
10% Owner
Transactions
- Sale
Common Stock
2010-10-28−2,209,741→ 0 total - Sale
Common Stock
2010-10-28−14,503→ 0 total - Sale
Common Stock
2010-10-28−132,802→ 0 total
Footnotes (7)
- [F1]Securities disposed of pursuant to that certain Agreement and Plan of Merger dated as of August 12, 2010 (attached as Exhibit 2.1 to Trubion's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 13, 2010), as amended, among the issuer and Emergent BioSolutions Inc. ("Emergent"), and certain affiliates, in exchange for (a) an aggregate of $3,217,367.79 cash, (b) 386,791 shares of Emergent common stock having a market value of $18.26 per share on the effective date of the merger and (c) 2,357,046 contingent value rights, which represent the right to receive possible additional cash payments.
- [F2]Securities held of record by ARCH Venture Fund V, L.P. ("ARCH V"). ARCH Venture Partners V, L.P. (the "GPLP"), as the sole general partner of ARCH V, may be deemed to beneficially own certain of the shares held of record by ARCH V. The GPLP disclaims beneficial ownership of all shares held of record by ARCH V in which the GPLP does not have an actual pecuniary interest. ARCH Venture Partners V, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by ARCH V. The GPLLC disclaims beneficial ownership of all shares held of record by ARCH V in which the GPLLC does not have an actual pecuniary interest.
- [F3]Each of Messrs. Crandell, Nelsen, Bybee and Lazarus, as the individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by ARCH V. Each of Messrs. Crandell, Nelsen, Bybee and Lazarus disclaims beneficial ownership of all shares held of record by ARCH V in which he does not have an actual pecuniary interest.
- [F4]Securities held of record by ARCH V Entrepreneurs Fund, L.P. ("Entrepreneurs"). The GPLP, as the sole general partner of Entrepreneurs, may be deemed to beneficially own certain of the shares held of record by Entrepreneurs. The GPLP disclaims beneficial ownership of all shares held of record by Entrepreneurs in which the GPLP does not have an actual pecuniary interest. The GPLLC, as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by Entrepreneurs. The GPLLC disclaims beneficial ownership of all shares held of record by Entrepreneurs in which the GPLLC does not have an actual pecuniary interest.
- [F5]Each of Messrs. Crandell, Nelsen, Bybee and Lazarus, as the individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by Entrepreneurs. Each of Messrs. Crandell, Nelsen, Bybee and Lazarus disclaims beneficial ownership of all shares held of record by Entrepreneurs in which he does not have an actual pecuniary interest.
- [F6]Securities held of record by Healthcare Focus Fund, L.P. ("Healthcare"). The GPLP, as the sole general partner of Healthcare, may be deemed to beneficially own certain of the shares held of record by Healthcare. The GPLP disclaims beneficial ownership of all shares held of record by Healthcare in which the GPLP does not have an actual pecuniary interest. The GPLLC, as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by Healthcare. The GPLLC disclaims beneficial ownership of all shares held of record by Healthcare in which the GPLLC does not have an actual pecuniary interest.
- [F7]Each of Messrs. Crandell, Nelsen, Bybee and Lazarus, as the individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by Healthcare. Each of Messrs. Crandell, Nelsen, Bybee and Lazarus disclaims beneficial ownership of all shares held of record by Healthcare in which he does not have an actual pecuniary interest.
Documents
Issuer
Trubion Pharmaceuticals, Inc
CIK 0001298521
Entity typeother
Related Parties
1- filerCIK 0001117120
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 4:18 PM ET
- Size
- 26.9 KB